If you experience persistent muscle weakness, fatigue and skin changes that don't seem to fade, it could be more than just ...
Received FDA orphan drug designation for the treatment of dermatomyositis in April 2017. Received FDA approval for the treatment of dermatomyositis in adults in July 2021. In ITP, Octagam 10% ...
Myositis-specific autoantibodies (MSAs ... She is recognized for her contributions to advancing treatment options and understanding of these challenging conditions. Financial Disclosures: Dr ...